Zy­dus gets US okay for skin oint­ment

The Hindu Business Line - - NEWS - PTI

Drug firm Zy­dus Cadila on Mon­day said it has re­ceived ap­proval from the US health reg­u­la­tor to mar­ket Clo­be­ta­sol Pro­pi­onate oint­ment, used to treat a range of skin con­di­tions, in the Amer­i­can mar­ket. The com­pany has re­ceived fi­nal ap­proval from the US Food and Drug Ad­min­is­tra­tion to mar­ket its prod­uct, Zy­dus Cadila said in a state­ment. The oint­ment will be man­u­fac­tured at the com­pany’s Ahmed­abad­based fa­cil­ity. The Zy­dus group has now more than 165 prod­uct ap­provals.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.